GitVibes daily briefing · 2026-10-24 · human
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
Curated by Kripa
Perspective
I'm cautious about the 68% remission claim without seeing the trial's control group details. My concern is whether the results are statistically significant compared to placebo.
Source summary
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.
Original reporting: ScienceDaily · Published 2026-10-23